Pictet Asset Management (UK)’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	$23.3M	Buy	68,486 +330	+0.5%	+$112K	0.03%	490
2021 Q1	$27.6M	Sell	68,156 -720	-1%	-$291K	0.03%	440
2020 Q4	$45.8M	Buy	68,876 +13,582	+25%	+$9.04M	0.06%	321
2020 Q3	$25.7M	Buy	55,294 +14,204	+35%	+$6.61M	0.04%	386
2020 Q2	$24M	Buy	+41,090	New	+$24M	0.04%	369